Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Mini Oral session - Developmental and precision medicine

NRG1-fusion-driven solid tumours: A case series indicating the therapeutic potential of afatinib

Date

22 Nov 2019

Session

Mini Oral session - Developmental and precision medicine

Topics

Cytotoxic Therapy

Tumour Site

Presenters

Yasushi Goto

Citation

Annals of Oncology (2019) 30 (suppl_9): ix22-ix29. 10.1093/annonc/mdz420

Authors

Y. Goto1, J. Cadranel2, B.A. Weinberg3, M. Duruisseaux4, S.V. Liu5, K. Tolba6, E. Branden7, R.C. Doebele8, C. Heining9, R.F. Schlenk10, J.J. Laskin11, P.K. Cheema12, M.R. Jones13, D. Trombetta14, L.A. Muscarella14, A. Cseh15, F. Solca16, D.J. Renouf11

Author affiliations

  • 1 Department Of Thoracic Oncology, National Cancer Center Hospital, 104-0045 - Tokyo/JP
  • 2 Department Of Pneumology, Assistance Publique Hôpitaux De Paris, Hôpital Tenon and Sorbonne Université, Paris/FR
  • 3 Division Of Hematology And Oncology, Georgetown University Medical Center, Washington/US
  • 4 Department Of Respiratory Medicine, Hospices Civils de Lyon Cancer Institute, Lyon/FR
  • 5 Division Of Medical Oncology, Georgetown University Medical Center, Washington/US
  • 6 Knight Cancer Institute, Oregon Health and Science University, Portland/US
  • 7 Department Of Respiratory Medicine, Gävle Hospital, Gävle/SE
  • 8 Department Of Medicine, University of Colorado Cancer Center, Aurora/US
  • 9 Department Of Translational Medical Oncology, National Center for Tumor Diseases Dresden, Dresden/DE
  • 10 Nct Trial Center, National Center Of Tumor Diseases Heidelberg, Heidelberg University Hospital and German Cancer Research Center, Heidelberg/DE
  • 11 Division Of Medical Oncology, University of British Columbia, BC Cancer, Vancouver/CA
  • 12 Faculty Of Medicine, William Osler Health System, University of Toronto, Toronto/CA
  • 13 Precision Oncology, Bioinformatic Business Area, QIAGEN Inc., Redwood City/US
  • 14 Laboratory Of Oncology, Fondazione IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo/IT
  • 15 Department Of Medical Affairs, Boehringer Ingelheim RCV GmbH & Co KG, Vienna/AT
  • 16 Department Of Pharmacology, Boehringer Ingelheim RCV GmbH & Co. KG, Vienna/AT

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.